Bayer and Johnson & Johnson announce that they have reached a $775 million agreement to settle approximately 25,000 outstanding litigation cases, which claim that their drug Xarelto caused severe and sometimes fatal bleeding episodes. Bayer and Johnson & Johnson had successfully defended the safety of the drug in all six prior cases that went to trial.